Welcome to our dedicated page for UPH news (Ticker: UPH), a resource for investors and traders seeking the latest updates and insights on UPH stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect UPH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of UPH's position in the market.
UpHealth (NYSE: UPH) reported a significant increase in digital clinic consultations across India, with a remarkable 380% growth, resulting in over 173,000 consultations by March 31, 2022. This growth reflects a successful adoption of HelloLyf™ dispensaries, especially in rural areas, helping to address the healthcare gap for women and children. The expansion includes plans for additional clinics in Odisha, contributing to better access to affordable care. Key specialties include internal medicine, obstetrics/gynecology, and pediatrics.
UpHealth, Inc. (NYSE: UPH) has announced its upcoming financial results for the first quarter ended March 31, 2022, scheduled for release before the market opens on May 12, 2022. A conference call will follow at 8:30 a.m. Eastern Time the same day. UpHealth specializes in digital health technology, aiming to enhance healthcare delivery and management via innovative infrastructure and services. The company caters to various clients, including health plans and community-based organizations, focusing on improving access and patient outcomes.
UpHealth reported pro forma revenue of $148.9 million for 2021, a 28% increase year-over-year. The company experienced a gross margin of 35% but reported a GAAP net loss per share of ($3.19). Adjusted EBITDA was negative $4.0 million. UpHealth completed a successful business combination with GigCapital2 and integrated six companies. The 2022 outlook projects revenue between $205 million and $233 million, with gross margins of 42%-43% and adjusted EBITDA of $14 million to $19 million.
UpHealth, Inc. (NYSE: UPH) has announced its 2022 Annual Meeting of Stockholders scheduled for June 28, 2022, at 9:00 a.m. PT. Only stockholders of record as of May 18, 2022, are eligible to vote. Information regarding the virtual meeting and participation will be provided in the definitive proxy statement to be filed with the SEC and will be accessible on UpHealth's website. UpHealth focuses on digital health solutions, helping clients improve healthcare delivery and patient outcomes at reduced costs.
UpHealth, Inc. (NYSE: UPH) has announced a credentialing partnership with New Directions Blue Cross Blue Shield Florida for its Olympus Recovery facility in Delray Beach, Florida. This facility specializes in mental health and substance abuse recovery, particularly for veterans and first responders. The partnership aims to provide high-quality and cost-effective care, enhancing access to treatment for these critical populations. Olympus Recovery is now partnered with eight insurance providers and is credentialing with more insurers to broaden coverage, benefiting over 4 million patients in Florida.
UpHealth (NYSE: UPH) announced a search for a new CEO as part of its transition to the next phase of growth. Dr. Ramesh Balakrishnan will remain in his role until the new leader is appointed, expected within weeks. Co-chairman Dr. Avi Katz emphasized the completion of integrating six merged companies and highlighted the search's positive response, indicating a shortlist of qualified candidates. Dr. Balakrishnan's future role will be announced later. UpHealth aims to enhance healthcare delivery globally through digital health solutions.
UpHealth (NYSE: UPH) reported its financial results for Q4 and FY 2021, with pro forma revenue ranging from $148.9 to $156.7 million and a gross margin of 39%. Q4 GAAP revenue was between $33.9 and $41.7 million, with gross margins expanding to 36%-38%. The company announced a public offering of $40.25 million to enhance its balance sheet. Looking forward, UpHealth anticipates total revenue for 2022 to be between $205 and $233 million, indicating expected growth of 38% to 56%.
UpHealth, Inc. (NYSE: UPH) has announced the rescheduling of its analyst day to March 30, 2022, when it will release its financial results for the fourth quarter and full year ending December 31, 2021. A live Q&A session with investors will start at 11:00 a.m. EDT. UpHealth focuses on delivering digital health technology and infrastructure to enhance healthcare delivery, catering to health plans, governments, and community organizations.
UpHealth, Inc. (NYSE: UPH) has announced the appointment of Ashish Chona as its new Executive Vice President (EVP) of Integrated Care as of March 9, 2022. Chona will manage operations and client support for UpHealth's SyntraNet platform, aimed at enhancing integrated care delivery. CEO Ramesh Balakrishnan noted Chona's leadership will be pivotal for growth amid increasing demands for comprehensive health solutions. Chona has over 20 years of experience in technology and healthcare, having previously co-founded several successful companies.
UpHealth, Inc. (NYSE: UPH) has introduced a new logo as part of its rebranding efforts to enhance its digital transformation impact in healthcare. The new logo symbolizes the company's commitment to quality care and integrated healthcare delivery. Edna Boone Johnson, the chief communications officer, emphasized the mission to drive health outcomes globally.
The rebranding coincides with UpHealth’s inaugural Analyst Day on March 23, 2022, and is designed by Ketchum to communicate its values effectively across digital and physical platforms.